Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy
BACH2 overexpression locks T cells in a quiescent ineffective state We and others have shown ...
BACH2 overexpression locks T cells in a quiescent ineffective state We and others have shown ...
Our website uses cookies to improve your experience. Learn more about: Cookie Policy